Clinical Microbiology Newsletter最新文献_第4页

A Day in the life of a medical microbiology director: Navigating the diverse duties as a clinical conductor 医学微生物学主任的一天：作为临床指挥员，履行各种职责

Clinical Microbiology Newsletter Pub Date : 2024-07-01 DOI: 10.1016/j.clinmicnews.2024.06.001

Karissa Culbreath , Peera Hemarajata , Richard B. Thomson Jr. , Rebecca Yee

{"title":"A Day in the life of a medical microbiology director: Navigating the diverse duties as a clinical conductor","authors":"Karissa Culbreath , Peera Hemarajata , Richard B. Thomson Jr. , Rebecca Yee","doi":"10.1016/j.clinmicnews.2024.06.001","DOIUrl":"10.1016/j.clinmicnews.2024.06.001","url":null,"abstract":"<div><p>Clinical microbiology laboratories support a range of services such as infectious disease diagnosis, infection prevention, and antimicrobial stewardship. The role of the clinical microbiology laboratory is more pivotal than ever as we face emerging pathogens, increases in healthcare-associated infections, antibiotic-resistant organisms, and rapidly advancing technologies. In the wake of these challenges, it is crucial for a clinical microbiology laboratory to be directed by medical microbiologists (i.e. laboratory directors) as they can provide accurate laboratory oversight and professional competence. Medical microbiologists can be found pursuing leadership roles in academic medical centers, diagnostic reference laboratories, public health institutions, and commercial entities such as diagnostic and pharmaceutical companies. Given the diverse career trajectories that medical microbiologists can have, the perspectives of these laboratory directors may be different even though they all strive to meet the common goal of providing diagnosis and management of infectious diseases.</p></div>","PeriodicalId":39211,"journal":{"name":"Clinical Microbiology Newsletter","volume":"47 ","pages":"Pages 14-20"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141623984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Update on common Bartonella infections 常见巴顿氏菌感染的最新情况

Clinical Microbiology Newsletter Pub Date : 2024-05-26 DOI: 10.1016/j.clinmicnews.2024.05.002

Portia Mira, Elitza S. Theel

引用次数: 0

Aminoglycoside antibiotics: Trying to find a place in this world 氨基糖苷类抗生素：试图在这个世界上找到一席之地

Clinical Microbiology Newsletter Pub Date : 2024-04-01 DOI: 10.1016/j.clinmicnews.2024.03.002

Erin N. Deja

引用次数: 0

Erratum regarding previously published articles 关于以前发表的文章的勘误

Clinical Microbiology Newsletter Pub Date : 2024-04-01 DOI: 10.1016/j.clinmicnews.2024.05.003

引用次数: 0

Enter the Matrix: An Update on MALDI-ToF MS Advancements through 2024 进入矩阵：到 2024 年 MALDI-ToF MS 的最新进展

Clinical Microbiology Newsletter Pub Date : 2024-04-01 DOI: 10.1016/j.clinmicnews.2024.05.001

John A. Fissel

引用次数: 0

Erratum regarding previously published articles. 对之前已发表文章的勘误。

Clinical Microbiology Newsletter Pub Date : 2024-04-01 DOI: 10.1016/j.clinmicnews.2024.05.004

引用次数: 0

Diagnosing ocular infections in the clinical microbiology laboratory 在临床微生物学实验室诊断眼部感染

Clinical Microbiology Newsletter Pub Date : 2024-04-01 DOI: 10.1016/j.clinmicnews.2024.03.004

Ashleigh N. Riegler, Sixto M. Leal Jr

引用次数: 0

Clinical utility and interpretive guidance for SARS-CoV-2 serological testing SARS-CoV-2血清学检测的临床应用及解释性指导

Clinical Microbiology Newsletter Pub Date : 2023-12-15 DOI: 10.1016/j.clinmicnews.2024.03.001

Muhammad Morshed , Agatha Jassem , Danielle Luk , Alexander Cheong , Mel Krajden , Inna Sekirov

{"title":"Clinical utility and interpretive guidance for SARS-CoV-2 serological testing","authors":"Muhammad Morshed , Agatha Jassem , Danielle Luk , Alexander Cheong , Mel Krajden , Inna Sekirov","doi":"10.1016/j.clinmicnews.2024.03.001","DOIUrl":"10.1016/j.clinmicnews.2024.03.001","url":null,"abstract":"<div><div><span>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged in Wuhan, China, in 2019 and rapidly spread worldwide. Over 750 million people were infected and close to 7 million were killed from 2019 to July 2023 according to the World Health Organization. Early in the pandemic, it was suggested that </span>serological tests<span><span> can confirm atypical or remote cases and assist in clinical diagnosis when molecular testing was limited. Although clinical uses of serological testing are limited, testing remains useful to: 1) assess and differentiate vaccine from infection related immune responses (when whole cell </span>killed vaccines<span> are not used), 2) enable population-level vaccination/infection and/or hybrid immune response surveillance, 3) understand at the population-level how serological markers correlate with the subsequent risk of infection based on the vaccine product used and the circulating variant, and 4) understand how different types of immunosuppression<span> or other clinical factors impact the immune response. Seroprevalence<span> assessments for infection/vaccination and hybrid immunity was helpful to assist in early phase pandemic modeling and when integrated with vaccine status and epidemiological outcomes enabled assessment of near- and long-term vaccine efficacy. This article will provide an overview of SARS-CoV-2 immunity over time, serology testing technologies, and appropriate SARS-CoV-2 serology test utilization and interpretation.</span></span></span></span></div></div>","PeriodicalId":39211,"journal":{"name":"Clinical Microbiology Newsletter","volume":"45 24","pages":"Pages 209-218"},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143272011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Communication is the bridge between confusion and clarity: Microbiology science communication 沟通是混乱与清晰之间的桥梁：微生物学科学沟通

Clinical Microbiology Newsletter Pub Date : 2023-12-01 DOI: 10.1016/j.clinmicnews.2024.03.003

Andrea M. Prinzi , Erin Garcia de Jesús , Richard E. Davis

引用次数: 0

Laboratory Diagnosis of Adenoviral Infections in Transplant Recipients 移植受者腺病毒感染的实验室诊断

Clinical Microbiology Newsletter Pub Date : 2023-11-15 DOI: 10.1016/j.clinmicnews.2024.01.003

Joshua D. Shirley Ph.D., Joseph D. Yao M.D.

{"title":"Laboratory Diagnosis of Adenoviral Infections in Transplant Recipients","authors":"Joshua D. Shirley Ph.D., Joseph D. Yao M.D.","doi":"10.1016/j.clinmicnews.2024.01.003","DOIUrl":"10.1016/j.clinmicnews.2024.01.003","url":null,"abstract":"<div><div><span>Adenovirus (AdV) is a common cause of mild respiratory tract and </span>gastrointestinal tract infections<span><span><span><span><span> in immunocompetent children and adults. Among hematopoietic stem cell (HSCT) and solid organ </span>transplant (SOT) recipients, such infections can be severe and lead to significant morbidity and mortality. The prevalence of </span>AdV infections in immunocompromised individuals varies according to the degree of </span>immunosuppression<span> and age, with such infection due to either primary infections or reactivation of </span></span>latent virus<span><span><span>. Diagnosis of AdV is frequently made using molecular test methods, mainly qualitative and quantitative polymerase chain reaction (PCR) assays. Qualitative-PCR assays provide a presumptive diagnosis of AdV infections, while serial quantitative-PCR assay results provide clinical specificity in determining the significance of AdV detection in </span>immunocompromised patients. Since AdV can be detected in various clinical specimens obtained from asymptomatic individuals, clinical correlation of positive AdV DNA test results is essential for clinical management of </span>HSCT and SOT recipients.</span></span></div></div>","PeriodicalId":39211,"journal":{"name":"Clinical Microbiology Newsletter","volume":"45 22","pages":"Pages 189-199"},"PeriodicalIF":0.0,"publicationDate":"2023-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143240057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0